Metraipolis › archive › dc_523c07ed249b
Safety, Tolerability, and Pharmacokinetics of the Long-Acting SARS-CoV-2-Neutralizing Monoclonal Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) in… — Europe PMC PMID:40799036
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40799036
- DOI
- 10.1002/cpdd.1583
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T16:19:16.667Z
- SHA-256 of the archived text
d9cd1d70264cddaa96e1550c64ce7d366065af87c13eb04fcd6b276186430c80- Stable URL of this page
https://metraipolis.com/documento/dc_523c07ed249b
How to cite
Safety, Tolerability, and Pharmacokinetics of the Long-Acting SARS-CoV-2-Neutralizing Monoclonal Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) in… — Europe PMC PMID:40799036 — Europe PMC (en), https://europepmc.org/article/MED/40799036 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_523c07ed249b (Metraipolis archive dc_523c07ed249b, sha256 d9cd1d70264cddaa96e1550c64ce7d366065af87c13eb04fcd6b276186430c80)
BibTeX
@misc{dc523c07ed249b,
title = {Safety, Tolerability, and Pharmacokinetics of the Long-Acting SARS-CoV-2-Neutralizing Monoclonal Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) in… — Europe PMC PMID:40799036},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40799036},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_523c07ed249b; sha256 d9cd1d70264cddaa96e1550c64ce7d366065af87c13eb04fcd6b276186430c80},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40799036. Agents can read the archived copy with the MCP tool read_document.